Vanta Bioscience

Vanta Bioscience Interest Coverage

The Interest Coverage Ratio of Vanta Bioscience (540729.BO) as of Oct 19, 2026 is -2.16. In the previous year, Interest Coverage Ratio was -0.56 — a change of 287.91% (lower).

Interest Coverage

-2.16

YoY

287.91%

Last updated:

Interest Coverage Ratio of Vanta Bioscience is 2025 -2.16 . Interest Coverage Ratio of Vanta Bioscience was 2024 -0.56 . It decreases by 287.91% lower compared to the previous year.

The Vanta Bioscience Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
2.34 INR
Jan 1, 2019
2.18 INR
Jan 1, 2020
1.76 INR
Jan 1, 2021
1.30 INR
Jan 1, 2022
0.92 INR
Jan 1, 2023
-0.90 INR
Jan 1, 2024
-0.56 INR
Jan 1, 2025
-2.16 INR
The Vanta Bioscience Interest Coverage history
YEARInterest CoverageYoY
-2.16+287.91%
-0.56-38.43%
-0.90-198.52%
0.92-29.71%
1.30-25.89%
1.76-19.27%
2.18-6.62%
2.34—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vanta Bioscience Stock analysis

What does Vanta Bioscience do? Vanta Bioscience Ltd is a company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Headquartered in Secunderabad, India, the company provides preclinical contract research services. It went public through an IPO on October 6, 2017. Vanta Bioscience offers a range of services including testing and contract research in clinical research, pre-clinical research, biopharma services, analytical testing, and environmental studies. The company serves clients from various industries such as pharmaceuticals, medical devices, nutraceuticals, feed additives, biotechnology, agrochemicals, cosmetics, and chemicals. Their services include preclinical safety assessment, risk assessment for active pharmaceutical ingredients (APIs), excipients, extractables and leachables, and pharmaceutical impurities. Additionally, Vanta Bioscience provides services for determining health-based exposure limits, such as permitted daily exposure (PDE) or allowable daily exposure (ADE), as well as occupational exposure limits (OEL) for pharmaceutical manufacturers. The company's website is www.vantabio.com. Vanta Bioscience Ltd is listed on the Bombay Stock Exchange under the ticker 540729.BO and has the ISIN INE695X01011. The company focuses on delivering comprehensive preclinical research solutions to support the development and safety evaluation of products across multiple sectors. Vanta Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vanta Bioscience stock

Interest Coverage Ratio of Vanta Bioscience is -2.16 in 2025.

Interest Coverage Ratio of Vanta Bioscience changed from -0.56 to -2.16, representing a 287.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Vanta Bioscience since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Vanta Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Vanta Bioscience

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Vanta Bioscience